about
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects.Towards a commercial process for the manufacture of genetically modified T cells for therapy.Adoptive T-cell therapy: a need for standard immune monitoring.Advancing Immune and Cell-Based Therapies Through Imaging.Electroporation of mRNA as Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins.Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells.Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanoma.
P2860
Q34256494-71B767DC-DE91-432A-9433-8DCE120E5E61Q38329158-9FA337B4-5A9C-4E04-9DCB-C8AFEC9FA834Q38525029-0999527D-9061-436F-B544-E4CDEFCA1BA5Q39167485-CC29D0F9-0BE8-4A71-874F-82186D85DB83Q50035982-6AF3A957-6D59-491F-9C98-12CAA9007220Q52675063-9B1F91FB-6F94-4D2C-914A-7F5E8CDD6437Q52859139-1395177E-2612-45B3-AD31-8D8A49225095
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Engineered T cells for cancer treatment
@ast
Engineered T cells for cancer treatment
@en
Engineered T cells for cancer treatment.
@nl
type
label
Engineered T cells for cancer treatment
@ast
Engineered T cells for cancer treatment
@en
Engineered T cells for cancer treatment.
@nl
prefLabel
Engineered T cells for cancer treatment
@ast
Engineered T cells for cancer treatment
@en
Engineered T cells for cancer treatment.
@nl
P2093
P2860
P1433
P1476
Engineered T cells for cancer treatment
@en
P2093
Ann M Leen
Juan F Vera
Malcolm K Brenner
Usanarat Anurathapan
P2860
P304
P356
10.1016/J.JCYT.2013.10.002
P577
2013-11-13T00:00:00Z